sertraline has been researched along with Central Nervous System Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corkeron, MA | 1 |
Cohen, CI; Trappler, B | 1 |
Anand, VS; Dewan, MJ | 1 |
1 trial(s) available for sertraline and Central Nervous System Diseases
Article | Year |
---|---|
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
2 other study(ies) available for sertraline and Central Nervous System Diseases
Article | Year |
---|---|
Serotonin syndrome--a potentially fatal complication of antidepressant therapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Central Nervous System Diseases; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine | 1995 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |